Ebola vaccine trial in west Africa faces criticism

@article{Shuchman2015EbolaVT,
  title={Ebola vaccine trial in west Africa faces criticism},
  author={Miriam Shuchman},
  journal={The Lancet},
  year={2015},
  volume={385},
  pages={1933-1934}
}
As the incidence of Ebola falls in west Africa, with Liberia declared Ebola free on May 9 and total cases in Sierra Leone and Guinea dipping to the lowest this year, investigators testing Ebola vaccines are racing to complete their studies. “Instead of a scramble for Africa, you have a scramble for patients, and the fear is that sometimes the patient gets lost”, Rebecca Freeman Grais, director of research at Medecins Sans Frontieres’ (MSF) Epicentre and a coinvestigator on a vaccine trial in… 
Adenovirus-vectored Ebola vaccines
TLDR
The progress that has been made in producing and testing adenovirus-based Ebola vaccines in both pre-clinical and clinical studies is described, and the likely future use of these vaccines is considered.
Research priorities during infectious disease emergencies in West Africa
TLDR
It was concluded that community members have valuable perspectives to share about research priorities during infectious disease emergencies, and well designed consultative processes could help identify these opinions.
Ethical Rationale for the Ebola "Ring Vaccination" Trial Design.
TLDR
It is argued that the ring vaccination design is ethical but fundamentally equivalent to placebo-controlled designs with respect to withholding a potentially effective intervention from the control group.
Global Bioheroes: clinical research and new vaccines for health security
  • C. Enemark
  • Political Science
    Australian Journal of International Affairs
  • 2018
ABSTRACT In the pursuit of ‘global health security’, some governments advocate deployment of pharmaceuticals to combat deadly infectious diseases wherever they emerge. Following the Ebola outbreak in
THE EFFECT OF EBOLA VIRUS ON HUMAN IMMUNE SYSTEM
TLDR
There are a few treatment methods which have been proven effective against the Zaire EBOV and some monoclonal antibody-based drugs have also been used.
Ethical Considerations in Vaccine Trials in Resource-Limited Settings
Abstract This chapter focuses on ethical concerns in trials designed to test safety, immunogenicity and efficacy of vaccines in human participants. Because vaccine trials may involve organizations in
Computational Models for Trapping Ebola Virus Using Engineered Bacteria
TLDR
The paper presents the analysis of the chemical binding force between the virus and a genetically engineered bacterium considering the opposing forces acting on the attachment point, including hydrodynamic tension and drag force.
Just health care in Nigeria : the foundations for an African ethical framework
Countries in Sub-Saharan Africa share at least three things: cultural heritage, a high burden of disease and a low financial commitment to health care. This thesis asks questions of justice about
Engineering Trojan-horse Bacteria to Trap Virus: A Mechanistic Model for Ebola Virus
The outbreak of Ebola virus disease in recent years has resulted in numerous research initiatives to seek new solutions to control and contain the spreading of the virus. A number of approaches that
Good collaborative practice: reforming capacity building governance of international health research partnerships
TLDR
It is found that governance of collaborative research partnerships, and in particular capacity building, in resource-constrained settings is limited but has improved with the implementation guidance of the International Ethical Guidelines for Health-related Research Involving Humans by The Council for International Organizations of Medical Sciences (CIOMS).
...
1
2
...